NEULAND LABORATORIES
Back to Balance Sheet
|
NEULAND LABORATORIES Last 5 Year Total Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹2,180 Cr | ₹1,833 Cr | ₹1,580 Cr | ₹1,383 Cr | ₹1,325 Cr |
What is the latest Total Liabilities ratio of NEULAND LABORATORIES ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹2,180 Cr |
| Mar2024 | ₹1,833 Cr |
| Mar2023 | ₹1,580 Cr |
| Mar2022 | ₹1,383 Cr |
| Mar2021 | ₹1,325 Cr |
How is Total Liabilities of NEULAND LABORATORIES Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹2,180 Cr | 18.95 | |
| Mar2024 | ₹1,833 Cr | 16.00 | |
| Mar2023 | ₹1,580 Cr | 14.19 | |
| Mar2022 | ₹1,383 Cr | 4.43 | |
| Mar2021 | ₹1,325 Cr | - | |
Compare Total Liabilities of peers of NEULAND LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NEULAND LABORATORIES | ₹22,960.1 Cr | 3.4% | 5.2% | 47.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹446,792.0 Cr | 1.4% | 1.2% | 13.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹178,152.0 Cr | -0.5% | -0.6% | 4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹152,915.0 Cr | 2.1% | 1.5% | 42.2% | Stock Analytics | |
| CIPLA | ₹116,354.0 Cr | 6.4% | 1.6% | -3.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹112,681.0 Cr | 6.2% | 1.6% | 0.2% | Stock Analytics | |
NEULAND LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NEULAND LABORATORIES | 3.4% |
5.2% |
47.6% |
| SENSEX | -0.4% |
0.8% |
-5.3% |
You may also like the below Video Courses